Literature DB >> 4139403

Intensive immunosuppression in the treatment of multiple sclerosis.

J Ring, J Seifert, G Lob, K Coulin, H Angstwurm, E Frick, B Brass, J Mertin, H Backmund, W Brendel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4139403     DOI: 10.1016/s0140-6736(74)90866-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology.

Authors:  J Ring; H Behrendt
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

2.  Editorial: Current status of antilymphocyte globulin.

Authors: 
Journal:  Br Med J       Date:  1975-03-22

3.  Editorial: Immunotherapy for multiple sclerosis.

Authors: 
Journal:  Br Med J       Date:  1975-11-29

4.  Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.

Authors:  E M Lance; M Kremer; J Abbosh; V E Jones; S Knight; P B Medawar
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

Review 5.  Epidemiology and infection in famine and disasters.

Authors:  P Shears
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

6.  Multiple sclerosis: recent advances in diagnosis clinical immunology and virology.

Authors:  D W Paty
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

7.  Failure of basic protein therapy for multiple sclerosis.

Authors:  R E Gonsette; P Delmotte; L Demonty
Journal:  J Neurol       Date:  1977-08-18       Impact factor: 4.849

8.  Role of toll-like receptors in multiple sclerosis.

Authors:  Socorro Miranda-Hernandez; Alan G Baxter
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

9.  Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.

Authors:  V E Jones; E M Lance; J Abbosh; H E Graves
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

10.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.